Physicians’ influence on breast cancer patient compliance
[english] In recent years there have been major advances in the treatment of breast cancer. However, taking the prescribed medication for a sufficient period of time is crucial to the success of any therapy. Thus far, no database-based studies have been published in German-speaking countries empiric...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
German Medical Science GMS Publishing House
2014-01-01
|
| Series: | GMS German Medical Science |
| Subjects: | |
| Online Access: | http://www.egms.de/static/en/journals/gms/2014-12/000188.shtml |
| _version_ | 1818379471533637632 |
|---|---|
| author | Kostev, Karel Waehlert, Lilia Jockwig, Achim Jockwig, Barbara Hadji, Peyman |
| author_facet | Kostev, Karel Waehlert, Lilia Jockwig, Achim Jockwig, Barbara Hadji, Peyman |
| author_sort | Kostev, Karel |
| collection | DOAJ |
| description | [english] In recent years there have been major advances in the treatment of breast cancer. However, taking the prescribed medication for a sufficient period of time is crucial to the success of any therapy. Thus far, no database-based studies have been published in German-speaking countries empirically examining the influence of the physician on the compliance of patients. The aim of this study is to investigate, quantify, and critically discuss the effect treating physicians have on the compliance of their breast cancer patients. Patients with a confirmed breast cancer diagnosis who started therapy (tamoxifen or aromatase inhibitors) between January 2001 and December 2011 were selected from the representative IMS Disease Analyzer database and analyzed with regard to their compliance. Practices were grouped into two categories concerning the compliance of all treated patients. A regression model showed that a breast cancer patient who is treated in a practice with a trend toward poor compliance has a nearly 60% higher risk for treatment discontinuation than would be the case in a practice with good compliance. It shows how important it is to motivate physicians to strive toward good compliance rates. |
| first_indexed | 2024-12-14T02:03:19Z |
| format | Article |
| id | doaj.art-f2aee6ba8317412db0578d57bd378801 |
| institution | Directory Open Access Journal |
| issn | 1612-3174 |
| language | deu |
| last_indexed | 2024-12-14T02:03:19Z |
| publishDate | 2014-01-01 |
| publisher | German Medical Science GMS Publishing House |
| record_format | Article |
| series | GMS German Medical Science |
| spelling | doaj.art-f2aee6ba8317412db0578d57bd3788012022-12-21T23:20:57ZdeuGerman Medical Science GMS Publishing HouseGMS German Medical Science1612-31742014-01-0112Doc0310.3205/000188Physicians’ influence on breast cancer patient complianceKostev, Karel0Waehlert, Lilia1Jockwig, Achim2Jockwig, Barbara3Hadji, Peyman4IMS Health, Frankfurt, GermanyHochschule Fresenius, Fachbereich Wirtschaft & Medien, Idstein, GermanyHochschule Fresenius, Fachbereich Wirtschaft & Medien, Idstein, GermanyGynäkologische Praxis, Oberursel, GermanyPhilipps-Universität, Klinik für Gynäkologie, Endokrinologie und Onkologie, Marburg, Germany[english] In recent years there have been major advances in the treatment of breast cancer. However, taking the prescribed medication for a sufficient period of time is crucial to the success of any therapy. Thus far, no database-based studies have been published in German-speaking countries empirically examining the influence of the physician on the compliance of patients. The aim of this study is to investigate, quantify, and critically discuss the effect treating physicians have on the compliance of their breast cancer patients. Patients with a confirmed breast cancer diagnosis who started therapy (tamoxifen or aromatase inhibitors) between January 2001 and December 2011 were selected from the representative IMS Disease Analyzer database and analyzed with regard to their compliance. Practices were grouped into two categories concerning the compliance of all treated patients. A regression model showed that a breast cancer patient who is treated in a practice with a trend toward poor compliance has a nearly 60% higher risk for treatment discontinuation than would be the case in a practice with good compliance. It shows how important it is to motivate physicians to strive toward good compliance rates.http://www.egms.de/static/en/journals/gms/2014-12/000188.shtmlbreast cancercompliancepersistenceDisease Analyzer |
| spellingShingle | Kostev, Karel Waehlert, Lilia Jockwig, Achim Jockwig, Barbara Hadji, Peyman Physicians’ influence on breast cancer patient compliance GMS German Medical Science breast cancer compliance persistence Disease Analyzer |
| title | Physicians’ influence on breast cancer patient compliance |
| title_full | Physicians’ influence on breast cancer patient compliance |
| title_fullStr | Physicians’ influence on breast cancer patient compliance |
| title_full_unstemmed | Physicians’ influence on breast cancer patient compliance |
| title_short | Physicians’ influence on breast cancer patient compliance |
| title_sort | physicians influence on breast cancer patient compliance |
| topic | breast cancer compliance persistence Disease Analyzer |
| url | http://www.egms.de/static/en/journals/gms/2014-12/000188.shtml |
| work_keys_str_mv | AT kostevkarel physiciansinfluenceonbreastcancerpatientcompliance AT waehlertlilia physiciansinfluenceonbreastcancerpatientcompliance AT jockwigachim physiciansinfluenceonbreastcancerpatientcompliance AT jockwigbarbara physiciansinfluenceonbreastcancerpatientcompliance AT hadjipeyman physiciansinfluenceonbreastcancerpatientcompliance |